The cholinergic anti-inflammatory system limits T cell infiltration into the neurodegenerative CNS, but cannot counteract complex CNS inflammation

Neurobiology of Disease

Volumn 35, Issue 1, 2009, Pages 24-31

  Nicolussi, Eva Maria ^a   Huck, Sigismund ^a   Lassmann, Hans ^a   Bradl, Monika ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BUNGAROTOXIN RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL INFILTRATION; CELL TRANSPORT; CHOLINERGIC SYSTEM; DEGENERATIVE DISEASE; DEMYELINATION; EXPERIMENTAL MODEL; FACIAL NERVE; FACIAL NERVE NUCLEUS; MOTONEURON NUCLEUS; MOUSE; NERVE FIBER TRANSECTION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; WILD TYPE;

ACETYLCHOLINE; ANIMALS; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION; CELL MOVEMENT; CENTRAL NERVOUS SYSTEM; CYTOKINES; DISEASE MODELS, ANIMAL; FACIAL NERVE DISEASES; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELIN-ASSOCIATED GLYCOPROTEIN; NERVE TISSUE PROTEINS; NEURITIS, AUTOIMMUNE, EXPERIMENTAL; NEURONS; NITRIC OXIDE SYNTHASE TYPE II; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, NICOTINIC; T-LYMPHOCYTES; VESICULAR ACETYLCHOLINE TRANSPORT PROTEINS;

EID: 67349175230     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2009.03.010     Document Type: Article

References (48)

1. Ashwell J.D., Lu F.W.M., and Vacchio M.S. Glucocorticoids in T cell development and function. Ann. Rev. Immunol. 18 (2000) 309-345
2. Bernik T.R., Friedman S.G., Ochani M., DiRaimo R., Ulloa L., Yang H., Sudan S., Czura C.J., Ivanova S.M., and Tracey K.J. Pharmacological stimulation of the cholinergic anti-inflammatory pathway. J. Exp. Med. 195 (2002) 781-788
3. Blalock J.E. Harnessing a neural-immune circuit to control inflammation and shock. J. Exp. Med. 195 (2002) F25-F28
4. Borovikova L.V., Ivanova S., Zhang M., Yang H., Botchkina G.I., Watkins L.R., Wang H., Abumrad N., Eaton J.W., and Tracey K.J. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405 (2000) 458-462
5. Bruijn L.I., Miller T.M., and Cleveland D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 27 (2005) 723-749
6. Chabas D., Baranzini S.E., Mitchell D., Bernard C.C., Rittling S.R., Denhardt D.T., Sobel R.A., Lock C., Karpuj M., Pedotti R., Heller R., Oksenberg J.R., and Steinman L. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294 (2001) 1731-1735
7. Coggan J.S., Bartol T.M., Esquenazi E., Stiles J.R., Lamont S., Martone M.E., Berg D.K., Ellisman M.H., and Sejnowski T. Evidence for ectopic neurotransmission at a neuronal synapse. Science 309 (2005) 446-451
8. Cullheim S., and Thams S. The microglial networks of the brain and their role in neuronal network plasticity after lesion. Brain Res. Rev. 55 (2007) 89-96
9. DeSimone R., Ajmone-Cat M.A., Carnevale D., and Minghetti L. Activation of a7 nicotinic acetylcholine receptor by nicotine selectively up-regulates cyclooxygenase-2 and prostaglandin E2 in rat microglial cultures. J. Neuroinflammation 2 (2003) 4
10. Fu Y., Hashimoto M., Ino H., Murakami M., Yamazaki M., and Moriya H. Spinal root avulsion-induced upregulation of osteopontin expression in the adult rat spinal cord. Acta Neuropathol. (Berl) 107 (2004) 8-16
11. Galiano M., Liu Z.Q., Kalla R., Bohatschek M., Koppius A., Gschwendtner A., Xu S., Werner A., Kloss C.U., Jones L.L., Bluethmann H., and Raivich G. Interleukin-6 (IL6) and cellular response to facial nerve injury: effects on lymphocyte recruitment, early microglial activation and axonal outgrowth in IL6-deficient mice. Eur. J. Neurosci. 14 (2001) 327-341
12. Hamano R., Takahahi H.K., Iwagaki H., Yoshino T., Nishibori M., and Tanaka N. Stimulation of alpha7 nicotinic acetylcholine receptor inhibits CD14 and the toll-like receptor 4 expression in human monocytes. Shock 26 (2006) 358-364
13. Hashimoto M., Sun D., Rittling S.R., Denhardt D.T., and Young W. Osteopontin-deficient mice exhibit less inflammation, greater tissue damage, and impaired locomotor recovery from spinal cord injury compared with wild-type controls. J. Neurosci. 27 (2007) 3603-3611
14. Hur E.M., Youssef S., Haws M.E., Zhang S.Y., Sobel R.A., and Steinman L. Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nat. Immunol. 8 (2007) 74-83
15. Jansson M., Panoutsakopoulou V., Baker J., Klein L., and Cantor H. Cutting edge: attenuated experimental autoimmune encephalomyelitis in Eta-1/Osteopontin-deficient mice. J. Immunol. 168 (2002) 2096-2099
16. Kastelein R.A., Hunter C.A., and Cua D.J. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Ann. Rev. Immunol. 25 (2007) 221-242
17. Kawakami N., Lassmann S., Li Z., Odoardi F., Ritter T., Ziemssen T., Klinkert W.E., Ellwart J.W., Bradl M., Krivacic K., Lassmann H., Ransohoff R.M., Volk H.D., Wekerle H., Linington C., and Flügel A. The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis. J. Exp. Med. 199 (2004) 185-197
18. Kim M.D., Cho H.S., and Shin T. Expression of osteopontin and its ligand, CD44, in the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis. J. Neuroimmunol. 151 (2004) 78-84
19. Li M.O., Wan Y.Y., Sanjabi S., Robertson A.-K.L., and Flavell R.A. Transforming growth factor-b regulation of immune responses. Ann. Rev. Immunol. 24 (2007) 99-146
20. Lucic V., and Baumeister W. Monte Carlo places strong odds on ectopic release. Science 309 (2005) 387-388
21. Masuda N., Ohnishi T., Kawamoto S., Monden M., and Okubo K. Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples. Nucleic Acid Res. 27 (1999) 4436-4443
22. Matsui K., and Jahr C.E. Ectopic release of synaptic vesicles. Neuron 40 (2003) 1173-1183
23. Matsui K., Jahr C.E., and Rubio M.E. High-concentration rapid transients of glutamate mediate neural-glial communication via ectopic release. J. Neurosci 25 (2005) 7538-7547
24. Moran L.B., and Graeber M.B. The facial nerve axotomy model. Brain Res. Rev. 44 (2004) 154-178
25. Nagao M., Misawa H., Kato S., and Hirai S. Loss of cholinergic synapses on the spinal motor neurons of amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 57 (1998) 329-333
26. Orr-Urteger A., Göldner F.M., Saeki M., Lorenzo I., Goldberg L., De Biasi M., Dani J.A., Patrick J.W., and Beaudet A.L. Mice deficient in the α7 neuronal nicotinic acetylcholine receptor lack α-bungarotoxin binding sites and hippocampal fast nicotinic currents. J. Neurosci. 17 (1997) 9165-9171
27. Park H.J., Lee P.H., Ahn Y.W., Choi Y.J., Lee G., Lee D.Y., Chung E.S., and Jin B.K. Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action. Eur. J. Neurosci. 26 (2007) 79-89
28. Pavlov V.A., and Tracey K.J. Controlling inflammation: the cholinergic anti-inflammatory pathway. Biochem. Soc. Trans. 34 (2006) 1037-1040
29. Pavlov V.A., Wang H., Czura C.J., Friedman S.G., and Tracey K.J. The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol. Med. 9 (2003) 125-129
30. Raivich G., Jones L.L., Kloss C.U., Werner A., Neumann H., and Kreutzberg G.W. Immune surveillance in the injured nervous system: T lymphocytes invade the axotomized mouse facial motor nucleus and aggregate around sites of neuronal degeneration. J. Neurosci. 18 (1998) 5804-5816
31. Razani-Boroujerdi S., Boyd R.T., Dávila-García M.I., Nandi J.S., Mishra N.C., Singh S.P., Pena-Philippides J.C., Langley R., and Sopori M.L. T cells express a7-nicotinic acetylcholine receptor subunits that require a functional TCR and leukocyte-specific protein tyrosine kinase for nicotine-induced Ca2+ response. J. Immunol. 179 (2007) 2889-2898
32. Saeed R.W., Varma S., Peng-Nemeroff T., Sherry B., Balakhaneh D., Huston J., Tracey K.J., Al-Abed Y., and Metz C.N. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J. Exp. Med. 201 (2005) 1113-1123
33. Sargsyan S.A., Monk P.N., and Shaw P.J. Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis. Glia 51 (2005) 241-253
34. Schroeter M., Zickler P., Denhardt D.T., Hartung H.P., and Jander S. Increased thalamic neurodegeneration following ischaemic cortical stroke in osteopontin-deficient mice. Brain 129 (2006) 1426-1437
35. Serobyan N., Schraufstatter I.U., Strongin A., and Khaldoyanidi S.K. Nicotinic acetylcholine receptor-mediated stimulation of endothelial cells results in the arrest of haematopoietic progenitor cells on endothelium. Br. J. Haematol. 129 (2005) 257-265
36. Shytle R.D., Mori T., Townsend K., Vendrame M., Sun N., Zeng J., Ehrhart J., Silver A.A., Sanberg P.R., and Tan J. Cholinergic modulation of microglial activation by α7 nicotinic receptors. J. Neurochem. 89 (2004) 337-343
37. Sinclair C., Mirakhur M., Kirk J., Farrell M., and McQuaid S. Up-regulation of osteopontin and alphaBeta-crystallin in the normal-appearing white matter of multiple sclerosis: an immunohistochemical study utilizing tissue microarrays. Neuropathol. Appl. Neurobiol. 31 (2005) 292-303
38. Skok M.V., Grailhe R., Agenes F., and Changeux J.P. The role of nicotinic receptors in B-lymphocyte development and activation. Life Sci. 80 (2007) 2334-2336
39. Tracey K.J. The inflammatory reflex. Nature 420 (2002) 853-859
40. Tracey K.J. Physiology and immunology of the cholinergic antiinflammatory pathway. J. Clin. Invest. 117 (2007) 289-296
41. Trapp B.D., Wujek J.R., Criste G.A., Jalabi W., Yin X., Kidd G.J., Stohlman S., and Ransohoff R. Evidence for synaptic stripping by cortical microglia. Glia 55 (2007) 360-368
42. Walker L.M., Preston M.R., Magnay J.L., Thomas P.B., and El Haj A.J. Nicotinic regulation of c-fos and osteopontin expression in human-derived osteoblast-like cells and human trabecular bone organ culture. Bone 28 (2001) 603-608
43. Wang H., Yu M., Ochani M., Amella C.A., Tanovic M., Susarla S., Li J.H., Wang H., Yang H., Ulloa L., Al-Abed Y., Czura C.J., and Tracey K.J. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature 421 (2003) 384-388
44. Wang K.X., and Denhardt D.T. Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev. 19 (2008) 333-345
45. Ware C.F. Network communications: lymphotoxins, light and TNF. Annu. Rev. Immunol. 23 (2005) 787-819
46. Woodruff P.G., Koth L.L., Yang Y.H., Rodriguez M.W., Favoreto S., Dolganov G.M., Paquet A.C., and Erle D.J. A distinctive alveolar macrophage activation state induced by cigarette smoking. Am. J. Respir. Crit. Care Med. 172 (2005) 1383-1392
47. Yasukawa H., Sasaki A., and Yoshimura A. Negative regulation of cytokine signaling pathways. Ann. Rev. Immunol. 18 (2000) 143-164
48. Zhu B., Suzuki K., Goldberg H.A., Rittling S.R., Denhardt D.T., McCulloch C.A., and Sodek J. Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin. J. Cell Physiol 198 (2004) 155-167